| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.038 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |